Form D — Strella Biotechnology, Inc.
0001810011-26-000003 · filed Aug 14, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $3,250,000
- Total sold
- $1,761,591
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Strella Biotechnology, Inc.
- CIK
- 1810011
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1601 2nd Ave, STE 575
Seattle, WA 98101 - Phone
- 703-909-4543
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Katherine Sizov · Executive OfficerSeattle, WA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗